Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,904,914
+$283,744 QoQ
Shares Held
7,570
+1.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#2,001
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Van Cleef Asset Management,Inc holds $14,679,161 across 8 Drug Manufacturers - General names. ABBV ranks #4 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,838 | $4,276,346 | |
| 2 | LLY |
ELI LILLY & Co
|
2,762 | $3,312,825 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,933 | $2,432,890 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
7,570 | $1,904,914 | |
| 5 | PFE |
Pfizer Inc
|
44,347 | $1,067,875 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
4,952 | $625,635 | |
| 7 | AMGN |
Amgen Inc
|
1,572 | $569,252 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,494 | $489,424 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,904,914 | 7,570 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,621,170 | 7,454 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,714,588 | 7,504 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,730,761 | 7,475 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,387,509 | 7,475 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,614,351 | 7,705 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,369,178 | 7,705 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,521,583 | 7,705 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,321,561 | 7,705 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,403,080 | 7,705 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,201,792 | 7,755 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $1,141,054 | 7,655 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,034,726 | 7,680 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,478,953 | 9,280 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,506,205 | 9,320 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,223,995 | 9,120 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,444,298 | 9,430 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,528,697 | 9,430 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,276,822 | 9,430 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,045,260 | 9,690 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,099,929 | 9,765 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,073,001 | 9,915 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,083,822 | 10,115 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $894,731 | 10,215 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,105,997 | 11,265 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $789,709 | 10,365 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||